AS1810722 is a potent, orally bioavailable STAT6 inhibitor with an IC50 of 1.9 nM. This fused bicyclic pyrimidine also inhibits CYP3A4 and is a valuable research tool for studying STAT6-driven pathologies, including allergic asthma and atopic dermatitis, in both cellular and animal models.
Molecular Weight:
477.51
Purity:
99.13% (May vary between batches)
CAS Number:
[909561-15-5]
Formula:
C25H25F2N7O
Target:
STAT,Cytochromes P450
Application Notes:
Solubility: DMSO:62.5 mg/mL (130.89 mM)
* VAT and and shipping costs not included. Errors and price changes excepted